Leishmaniasis in humans and small animals: Updates and insights through a one health: Leishmaniasis in Humans and Small Animals

Amirhossein  Badkoubi; Niloofar  Sanaeiha; Narges  Safari; Zahra  Dolati; Amirreza  Khodakarami; Rastin Safari; Mohammad Arad Zandieh

doi:10.62310/liab.v5i2.195

Authors

Amirhossein Badkoubi Department of Pathobiology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran https://orcid.org/0009-0006-5301-1186
Niloofar Sanaeiha Department of veterinary clinical medicine, Faculty of Veterinary, Shabestar branch Islamic Azad university , Eastern Azerbaijan ,Iran https://orcid.org/0009-0002-7490-7812
Narges Safari Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran
Zahra Dolati Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran
Amirreza Khodakarami Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran
Rastin Safari Faculty of Veterinary Medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran
Mohammad Arad Zandieh Department of Food Hygiene and Quality Control, Division of Epidemiology & Zoonoses, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

DOI:

https://doi.org/10.62310/liab.v5i2.195

Keywords:

Leishmaniasis, Zoonoses, One health, Epidemiology, Diagnosis

Abstract

Leishmaniasis is neglected infectious disease caused by a type of microscopic parasite called Leishmania spp. This disease can affect both humans and animals, as well as sandflies. There are more than 90 species of sandflies that can transmit Leishmania parasites, with Lutzomyia being the primary transmitter in the Americas and Phlebotomus being the primary transmitter elsewhere. The disease, prevalent in tropical and subtropical regions, including southern Europe, poses a significant global health concern due to increasing outbreaks spurred by climate change and heightened human and animal mobility. Leishmaniasis is categorized into three main forms: cutaneous, visceral (kala-azar), and mucocutaneous. These forms vary in clinical presentation, ranging from skin lesions to severe systemic involvement of internal organs and mucosal damage. The treatment of leishmaniasis is complex and depends on factors such as the disease type, parasite species, geographic region, and the host's health status. This review adopts a One Health approach, integrating human, animal, and environmental perspectives to provide a comprehensive update on leishmaniasis. It synthesizes recent advances in understanding the epidemiology, clinical manifestations, diagnostic techniques, and treatment strategies of cutaneous, mucocutaneous, and visceral leishmaniasis in humans and small animals. Understanding interconnection between animals and humans requires a holistic approach such as One Health perspective. This framework emphasizes the need for coordinated research, innovative treatments, and integrated prevention strategies to combat its growing global burden.

Metrics

Metrics Loading ...

References

Abadías-Granado I, Diago A, Cerro PA, Palma-Ruiz AM, Gilaberte Y. (2021). Cutaneous and Mucocutaneous Leishmaniasis. Actas Dermo-Sifiliográficas 112(7): 601-618. https://doi.org/10.1016/j.ad.2021.02.008

Aghakhani N, Azami M, Mohaghegh MA. (2023). Cutaneous Leishmaniasis Lowers the Quality of Life: A Neglected Truth. GMS Hygiene and Infection Control 18: Doc21. https://doi.org/10.3205/dgkh000447

Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. (2014). Revisiting Leishmaniasis in the time of war: The Syrian conflict and the Lebanese outbreak. International Journal of Infectious Diseases 29: 115-119. https://doi.org/10.1016/j.ijid.2014.07.009

Alcover MM, Riera MC, Fisa R. (2021). Leishmaniosis in rodents caused by Leishmania infantum: A review of studies in the Mediterranean area. Frontiers in Veterinary Science 8: 702687. https://doi.org/10.3389/fvets.2021.702687.

Alemayehu B, Alemayehu M. (2017). Leishmaniasis: A review on parasite, vector, and reservoir host. Health Science Journal 11(4): 1. https://doi.org/10.21767/1791-809X.1000519

Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J. (2008). The relationship between leishmaniasis and AIDS: the second 10 years. Clinical Microbiology Reviews 21(2): 334-359. https://doi.org/10.1128/CMR.00061-07

Antinori S, Schifanella L, Corbellino M. (2012). Leishmaniasis: New insights from an old and neglected disease. European Journal of Clinical Microbiology & Infectious Diseases 31(2): 109–118. https://doi.org/10.1007/s10096-011-1276-0

Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A. (2017). Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). American Journal of Tropical Medicine and Hygiene 96(1): 24–45. https://doi.org/10.4269/ajtmh.16-84256

Artun O. (2019). Ecological niche modeling for the prediction of cutaneous leishmaniasis epidemiology in current and projected future in Adana, Turkey. Journal of Vector Borne Diseases 56(2): 127-133. https://doi.org/10.4103/0972-9062.263726

Ayele A, Seyoum Z. (2016). Review on canine leishmaniasis, etiology, clinical sign, pathogenesis, treatment and control methods. Global Veterinaria 17(4): 343-352. https://doi.org/10.5829/idosi.gv.2016.17.04.104151

Azian MN, Hakim SL, Khadri MS, Yusri MY, Adela JI, Noor M, Nurhainis OS, Karnan G, Shamilah H. (2016). Leishmaniasis in Peninsular Malaysia: the role of immigrant workers and the vector. Southeast Asian Journal of Tropical Medicine and Public Health 47(4): 607-616.

Baneth G, Shaw SE. (2002). Chemotherapy of canine leishmaniosis. Veterinary Parasitology 106(4): 315–324. https://doi.org/10.1016/S0304-4017(02)00115-2

Berman JD. (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infectious Diseases 24(4): 684–703. https://doi.org/10.1093/clind/24.4.684

Bilgic-Temel A, Murrell DF, Uzun S. (2019). Cutaneous leishmaniasis: A neglected disfiguring disease for women. International Journal of Women's Dermatology 5(3): 158-165. https://doi.org/10.1016/j.ijwd.2019.01.002

Boehme CC, Hain U, Novosel A, Eichenlaub S, Fleischmann E, Löscher T. (2006). Congenital visceral leishmaniasis. Emerging Infectious Diseases 12(2): 359–360. https://doi.org/10.3201/eid1202.050449d

Bueno I, Smith KM, Sampedro F, Machalaba CC, Karesh WB, Travis DA. (2016). Risk prioritization tool to identify the public health risks of wildlife trade: The case of rodents from Latin America. Zoonoses and Public Health 63(4): 281–293. https://doi.org/10.1111/zph.12228

Burza S, Croft SL, Boelaert M. (2018). Leishmaniasis. The Lancet 392(10151): 951–970. https://doi.org/10.1016/S0140-6736(18)31204-2

Carrillo E, Moreno J, Cruz I. (2013). What is responsible for a large and unusual outbreak of leishmaniasis in Madrid? Trends in Parasitology 29(12): 579–580. https://doi.org/10.1016/j.pt.2013.10.007

Carrió J, Riera C, Gállego M, Portús M. (2001). In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain. Acta Tropica 79(2): 179–183. https://doi.org/10.1016/s0001-706x(01)00125-5

Cecílio P, Cordeiro-da-Silva A, Oliveira F. (2022). Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites. Communications Biology 5(1): 305. https://doi.org/10.1038/s42003-022-03240-z

Cosma Claudia, Carla Maia, Nushrat Khan, Maria Infantino, and Marco Del Riccio. 2024. Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World. Tropical Medicine and Infectious Disease 9(11): 258. https://doi.org/10.3390/tropicalmed9110258

Costa CHN. (2008). Characterization and speculations on the urbanization of visceral leishmaniasis in Brazil. Cadernos de Saúde Pública 24: 2959-2963. https://doi.org/10.1590/S0102-311X2008001200027

Cunha MA, Celeste BJ, Kesper N, Fugimori M, Lago MM, Ibanes AS, Ouki LM, Neto EAS, Fonseca FF, Silva MAL, Júnior WLB, Lindoso JAL. (2020). Frequency of Leishmania spp. infection among HIV-infected patients living in an urban area in Brazil: a cross-sectional study. BMC Infectious Diseases 20(1): 885. https://doi.org/10.1186/s12879-020-05622-2

de Vries HJ, Reedijk SH, Schallig HD. (2015). Cutaneous leishmaniasis: Recent developments in diagnosis and management. American Journal of Clinical Dermatology 16(2): 99–109. https://doi.org/10.1007/s40257-015-0114-z

Dereure J, Vanwambeke SO, Malé P, Martinez S, Pratlong F, Balard Y, Dedet JP. (2009). The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France. Vector-Borne and Zoonotic Diseases 9(6), 687–694. https://doi.org/10.1089/vbz.2008.0126

Dutta AK. (2008). Pursuit of medical knowledge: Charles Donovan (1863–1951) on kala-azar in India. Journal of Medical Biography 16(2): 72-76. https://doi.org/10.1258/jmb.2007.007057

El Hajj R, El Hajj H, Khalifeh I. (2018). Fatal visceral leishmaniasis caused by Leishmania infantum, Lebanon. Emerging Infectious Diseases 24(5): 906–907. https://doi.org/10.3201/eid2405.180019

Esteva L, Vargas C, Vargas de León C. (2017). The role of asymptomatics and dogs on leishmaniasis propagation. Mathematical Biosciences 293: 46–55. https://doi.org/10.1016/j.mbs.2017.08.002

Gambino D, Otero L. (2021). Facing diseases caused by Trypanosomatid parasites: Rational design of Pd and Pt complexes with bioactive ligands. Frontiers in Chemistry 9: 816266. https://doi.org/10.3389/fchem.2021.816266

Georgiadou SP, Makaritsis KP, Dalekos GN. (2015). Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment. Journal of Translational Internal Medicine 3(2): 43-50. https://doi.org/10.1515/jtim-2015-0002

Ghosh P, Roy P, Chaudhuri SJ, Das NK. (2021). Epidemiology of post-kala-azar dermal leishmaniasis. Indian Journal of Dermatology 66(1): 12–23. https://doi.org/10.4103/ijd.IJD_651_20

González U, Pinart M, Sinclair D, Firooz A, Enk C, Vélez ID, Esterhuizen TM, Tristan M, Alvar J. (2015). Vector and reservoir control for preventing leishmaniasis. Cochrane Database of Systematic Reviews 2015(8): CD008736. https://doi.org/10.1002/14651858.CD008736.pub2

Gradoni L, Gramiccia M, Scalone A. (2003). Visceral leishmaniasis treatment, Italy. Emerging Infectious Diseases 9(12): 1617-1620. https://doi.org/10.3201/eid0912.030178

Hewawasam C, Weerakoon HS, Thilakan V, Lelwala T, Prasanka K, Rathnayaka AS, Gamage S, Agampodi S. (2020). Is leishmaniasis adequately notified in Sri Lanka? A survey among doctors from an endemic district, Sri Lanka. BMC Public Health 20(1): 913. https://doi.org/10.1186/s12889-020-09066-w

Hong A, Zampieri RA, Shaw JJ, Floeter-Winter LM, Laranjeira-Silva MF. (2020). One Health approach to leishmaniases: Understanding the disease dynamics through diagnostic tools. Pathogens 9(10): 809. https://doi.org/10.3390/pathogens9100809

Ikeogu NM, Akaluka GN, Edechi CA, Salako ES, Onyilagha C, Barazandeh AF, Uzonna JE. (2020). Leishmania immunity: Advancing immunotherapy and vaccine development. Microorganisms, 8(8): 1201. https://doi.org/10.3390/microorganisms8081201

Inceboz T. (2019). Epidemiology and ecology of leishmaniasis. In: Rodríguez-Morales AJ, editor, Current topics in neglected tropical diseases, Infotechopen, London, UK. Pp. 1-15. https://doi.org/10.5772/intechopen.86359

Jones CM, Welburn SC. (2021). Leishmaniasis beyond East Africa. Frontiers in Veterinary Science 8: 618766. https://doi.org/10.3389/fvets.2021.618766

Kaye PM, Cruz I, Picado A, Van Bocxlaer K, Croft SL. (2020). Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs. Seminars in Immunopathology 42(3): 247-264. https://doi.org/10.1007/s00281-020-00784-4

Kobets T, Grekov I, Lipoldova M. (2012). Leishmaniasis: prevention, parasite detection and treatment. Current Medicinal Chemistry 19(10): 1443–1474. https://doi.org/10.2174/092986712799828300

Kumar A, Singh VK, Tiwari R, Madhukar P, Rajneesh Kumar S, Gautam V, Engwerda C, Sundar S, Kumar R. (2023). Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination. Frontiers in Immunology 14: 1236952. https://doi.org/10.3389/fimmu.2023.1236952

Kumar P, Chatterjee M, Das NK. (2021). Post Kala-Azar dermal Leishmaniasis: Clinical features and differential diagnosis. Indian Journal of Dermatology 66(1): 24-33. https://doi.org/10.4103/ijd.IJD_602_20

Lindoso JA, Cunha MA, Queiroz IT, Moreira CH. (2016). Leishmaniasis-HIV coinfection: current challenges. HIV/AIDS (Auckland NZ) 8: 147-156. https://doi.org/10.2147/HIV.S93789

Macedo-Silva VP, Martins DR, De Queiroz PV, Pinheiro MP, Freire CC, Queiroz JW, Dupnik KM, Pearson RD, Wilson ME, Jeronimo SM, Ximenes FM. (2014). Feeding preferences of Lutzomyia longipalpis(Diptera: Psychodidae), the sand fly vector, for Leishmania infantum (Kinetoplastida: Trypanosomatidae). Journal of Medical Entomology 51(1): 237–244. https://doi.org/10.1603/ME12131

Magill AJ. (2005). Cutaneous leishmaniasis in the returning traveler. Infectious Disease Clinics 19(1): 241-266. https://doi.org/10.1016/j.idc.2004.11.005

Maia Z, Lírio M, Mistro S, Mendes CM, Mehta SR, Badaro R. (2012). Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. PLoS Neglected Tropical Disease 6(1): e1484. https://doi.org/10.1371/journal.pntd.0001484

Mann S, Frasca K, Scherrer S, Henao-Martínez AF, Newman S, Ramanan P, Suarez JA. (2021). A Review of Leishmaniasis: Current Knowledge and Future Directions. Current Tropical Medicine Reports 8(2): 121–132. https://doi.org/10.1007/s40475-021-00232-7

Manson-Bahr P, Southgate B, Harvey A. (1963). Development of Kala-azar in Man after Inoculation with a Leishmania from a Kenya Sandfly. British Medical Journal 1(5339): 1208-1210.

Marcondes M, Day MJ. (2019). Current status and management of canine leishmaniasis in Latin America. Research in Veterinary Science 123: 261-272. https://doi.org/10.1016/j.rvsc.2019.01.022

Marsden PD. (1986). Mucosal leishmaniasis ("espundia" Escomel, 1911). Transactions of The Royal Society of Tropical Medicine and Hygiene 80(6): 859-876. https://doi.org/10.1016/0035-9203(86)90243-9

Moafi M, Rezvan H, Sherkat R, Taleban R. (2019). Leishmania vaccines entered in clinical trials: A review of literature. International Journal of Preventive Medicine 10: 95. https://doi.org/10.4103/ijpvm.IJPVM_116_18

Modabber F. (1995). Vaccines against leishmaniasis. Annals of Tropical Medicine & Parasitology 89(1): 83–88. https://doi.org/10.1080/00034983.1995.11813017

Morales-Yuste M, Martín-Sánchez J, Corpas-Lopez V. (2022). Canine Leishmaniasis: Update on epidemiology, diagnosis, treatment, and prevention. Veterinary Sciences 9(8): 387. https://doi.org/10.3390/vetsci9080387

Morillas-Márquez F, Martín-Sánchez J, Díaz-Sáez V, Barón-López S, Morales-Yuste M, de Lima Franco FA, Sanchís-Marín MC. (2010). Climate change and infectious diseases in Europe: Leishmaniasis and its vectors in Spain. The Lancet Infectious Diseases 10(4): 216–217. https://doi.org/10.1016/S1473-3099(10)70052-9

Murray HW, Berman JD, Davies CR, Saravia NG. (2005). Advances in leishmaniasis. Lancet (London, England) 366(9496): 1561–1577. https://doi.org/10.1016/S0140-6736(05)67629-5

Negera E, Gadisa E, Yamuah L, Engers H, Hussein J, Kuru T, Hailu A, Gedamu L, Aseffa A. (2008). Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(9): 883–890. https://doi.org/10.1016/j.trstmh.2008.03.021

Ngure PK, Kimutai A, Rukunga G, Tonui WK. (2009). A review of Leishmaniasis in Eastern Africa. Journal of Nanjing Medical University 23(2): 79-86. https://doi.org/10.1016/S1007-4376(09)60032-0

Noli C, Auxilia ST. (2005). Treatment of canine Old World visceral leishmaniasis: a systematic review. Veterinary Dermatology 16(4): 213–232. https://doi.org/10.1111/j.1365-3164.2005.00460.x

Oryan A, Akbari M. (2016). Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine 9(10): 925–932. https://doi.org/10.1016/j.apjtm.2016.06.021

Palatnik-de-Sousa CB, Day MJ. (2011). One Health: the global challenge of epidemic and endemic leishmaniasis. Parasites & Vectors 4: 197. https://doi.org/10.1186/1756-3305-4-197

Palatnik-de-Sousa CB, Silva-Antunes I, Morgado AdeA, Menz I, Palatnik M, Lavor C. (2009). Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 27(27): 3505–3512. https://doi.org/10.1016/j.vaccine.2009.03.045

Pereira MA, Santos R, Oliveira R, Costa L, Prata A, Gonçalves V, Roquette M, Vala H, Santos-Gomes G. (2020). Prognostic factors and life expectancy in canine Leishmaniosis. Veterinary Sciences 7(3): 128. https://doi.org/10.3390/vetsci7030128

Piscopo TV, Mallia Azzopardi C. (2007). Leishmaniasis. Postgraduate Medical Journal 83(976): 649–657. https://doi.org/10.1136/pgmj.2006.047340corr1

Pradhan S, Schwartz RA, Patil A, Grabbe S, Goldust M. (2022). Treatment options for leishmaniasis. Clinical and Experimental Dermatology 47(3): 516–521. https://doi.org/10.1111/ced.14919

Priolo V, Ippolito D, Rivas-Estanga K, De Waure C, Martínez-Orellana P. (2024). Canine leishmaniosis global prevalence over the last three decades: A meta-analysis and systematic review. Comparative Immunology, Microbiology and Infectious Diseases 89: 102211. https://doi.org/10.1016/j.cimid.2024.102211

Ready PD. (2008). Leishmaniasis emergence and climate change. Revue Scientifique et Technique ('Office International des Epizooties) 27(2): 399–412. https://doi.org/10.20506/rst.27.2.1803

Registre C, Soares RDOA, Rubio KTS, Santos ODH, Carneiro SP. (2023). A systematic review of drug-carrying nanosystems used in the treatment of Leishmaniasis. ACS Infectious Diseases 9(3): 423–449. https://doi.org/10.1021/acsinfecdis.2c00632

Reimão JQ, Coser EM, Lee MR, Coelho AC. (2020). Laboratory diagnosis of cutaneous and visceral leishmaniasis: Current and future methods. Microorganisms 8(11): 1632. https://doi.org/10.3390/microorganisms8111632

Romero, G. A., M. V. de Farias Guerra, M. G. Paes and V. d. O. Macêdo (2001). "Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L.(V.) guyanensis in Brazil: clinical findings and diagnostic approach." Clinical Infectious Diseases 32(9): 1304-1312. https://doi.org/10.1086/319990

Ruiz-Postigo JA, Grout L, Saurabh J. (2020). Global leishmaniasis surveillance, 2017-2018, and first report on 5 additional indicators/Surveillance mondiale de la leishmaniose, 2017-2018, et premier rapport sur 5 indicateurs supplementaires. Weekly Epidemiological Record 95(25): 265-280.

Rupasinghe R, Chomel BB, Martínez-López B. (2022). Climate change and zoonoses: A review of the current status, knowledge gaps, and future trends. Acta Tropica 226: 106225. https://doi.org/10.1016/j.actatropica.2021.106225

Saadene Y, Salhi A, Mliki F, Bouslama Z. (2023). Climate change and cutaneous leishmaniasis in the province of Ghardaïa in Algeria: A model-based approach to predict disease outbreaks. Annals of Saudi Medicine 43(5): 263-276. https://doi.org/10.5144/0256-4947.2023.263

Salman SM, Rubeiz NG, Kibbi AG. (1999). Cutaneous leishmaniasis: clinical features and diagnosis. Clinics in Dermatology 17(3): 291–296. https://doi.org/10.1016/S0738-081X(99)00047-4

Salomón OD, Quintana MG, Mastrángelo AV, Fernández MS. (2012). Leishmaniasis and climate change-case study: Argentina. Journal of Tropical Medicine 2012: 601242. https://doi.org/10.1155/2012/601242

Silveira FT, Ishikawa EA, De Souza AA, Lainson R. (2002). An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region. Parasite 9(1): 43–50. https://doi.org/10.1051/parasite/200209143

Singh S, Sivakumar R. (2004). Challenges and new discoveries in the treatment of leishmaniasis. Journal of Infection and Chemotherapy 10(6): 307–315. https://doi.org/10.1007/s10156-004-0348-9

Su X, Guo Y, Deng J, Xu J, Zhou G, Zhou T, Li Y, Zhong D, Kong L, Wang X, Liu M, Wu K, Yan G, Chen XG. (2019). Fast emerging insecticide resistance in Aedes albopictus in Guangzhou, China: Alarm to the dengue epidemic. PLoS Neglected Tropical Diseases 13(9): e0007665. https://doi.org/10.1371/journal.pntd.0007665

Sykes JE. (2022). Greene's Infectious Diseases of the Dog and Cat. Saunders, Elsevier Philadelphia, USA.

Vélez ID, Carrillo LM, López L, Rodríguez E, Robledo SM. (2012). An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis. The American Journal of Tropical Medicine and Hygiene 86(5): 807–811. https://doi.org/10.4269/ajtmh.2012.11-0408

WHO. (2010). World Health Organization working to overcome the global impact of neglected tropical disease. First WHO Report on Neglected Disease, World Health Organization, Geneva, Switzerland.

Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. (2003). Post-kala-azar dermal leishmaniasis. The Lancet Infectious Diseases 3(2): 87–98. https://doi.org/10.1016/s1473-3099(03)00517-6